Jonathan Pan comments on cancer clinical trial participation
Scientia Advisors in the News
BioPharm Insight quotes Scientia Advisors' Jonathan Pan
Abigail Moss and Kimberly HaJune 14, 2011
BioPharm Insight quotes Jonathan Pan, Consultant, Engagement Manager at Scientia Advisors in an article evaluating patient enrollment difficulties in prostate cancer trials.
Johnathan Pan believes that overall participation in clinical cancer trials has decreased to a current level around 3%. "The question will be how many will participate in 2012," he said."
Read more at the BioPharm Insight website
SCIENTIA ADVISORS, LLC | info@scientiaadv.com
55 Cambridge Parkway, Suite 300E, Cambridge MA 02142 | Phone: 617-299-3000 | Fax: 617-812-0315
© 2012 Scientia Advisors LLC
